NeueHealth (NYSE:NEUE – Get Free Report) is one of 13 publicly-traded companies in the “Hospital & medical service plans” industry, but how does it contrast to its competitors? We will compare NeueHealth to similar companies based on the strength of its dividends, institutional ownership, profitability, valuation, risk, analyst recommendations and earnings.
Analyst Recommendations
This is a breakdown of recent ratings and price targets for NeueHealth and its competitors, as reported by MarketBeat.com.
Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
NeueHealth | 0 | 1 | 0 | 0 | 2.00 |
NeueHealth Competitors | 87 | 1097 | 2474 | 97 | 2.69 |
NeueHealth presently has a consensus target price of $8.00, suggesting a potential upside of 23.46%. As a group, “Hospital & medical service plans” companies have a potential upside of 15.23%. Given NeueHealth’s higher possible upside, analysts clearly believe NeueHealth is more favorable than its competitors.
Valuation & Earnings
Gross Revenue | Net Income | Price/Earnings Ratio | |
NeueHealth | $1.16 billion | -$1.15 billion | -0.04 |
NeueHealth Competitors | $86.71 billion | $2.99 billion | 11.89 |
NeueHealth’s competitors have higher revenue and earnings than NeueHealth. NeueHealth is trading at a lower price-to-earnings ratio than its competitors, indicating that it is currently more affordable than other companies in its industry.
Risk and Volatility
NeueHealth has a beta of 0.84, indicating that its share price is 16% less volatile than the S&P 500. Comparatively, NeueHealth’s competitors have a beta of 0.89, indicating that their average share price is 11% less volatile than the S&P 500.
Profitability
This table compares NeueHealth and its competitors’ net margins, return on equity and return on assets.
Net Margins | Return on Equity | Return on Assets | |
NeueHealth | -71.23% | N/A | -1.21% |
NeueHealth Competitors | 0.18% | -0.61% | 0.48% |
Institutional and Insider Ownership
63.9% of NeueHealth shares are held by institutional investors. Comparatively, 80.4% of shares of all “Hospital & medical service plans” companies are held by institutional investors. 64.3% of NeueHealth shares are held by insiders. Comparatively, 10.2% of shares of all “Hospital & medical service plans” companies are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.
Summary
NeueHealth competitors beat NeueHealth on 9 of the 12 factors compared.
About NeueHealth
NeueHealth, Inc., a healthcare company, provides various healthcare services for health consumers, providers, and payors in the United States. It operates through two segments: NeueCare and NeueSolutions. The NeueCare segment delivers healthcare services to ACA marketplace, medicare, and medicaid through owned and affiliated clinics. It operates risk-bearing clinics under the Centrum Health, AssociatesMD, and Premier Medical Associates brand names. The company also offers integrated system care solution, such as embedded pharmacy, laboratory, radiology, and population health focused specialty services; and chronic care management, transitions of care, and referral management services. The NeueSolutions segment enables providers and medical groups to succeed in performance-based arrangements; and participates in the centers for healthcare access to medicare beneficiaries. The company was formerly known as Bright Health Group, Inc. and changed its name to NeueHealth, Inc. in January 2024. NeueHealth, Inc. was incorporated in 2015 and is headquartered in Doral, Florida.
Receive News & Ratings for NeueHealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NeueHealth and related companies with MarketBeat.com's FREE daily email newsletter.